Zili Xiao

Design and synthesis of pfmrk inhibitors as potential antimalarial agents

Zili Xiao, Norman C. Waters, Cassandra L. Woodard et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 85 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Effects of Putative Hydroxylated Thalidomide Metabolites on Blood Vessel Density in the Chorioallantoic Membrane (CAM) Assay and on Tumor and Endothelial Cell Proliferation.

Megan G. Marks, Jiandong Shi, Michael O. Fry et al. · Biological and Pharmaceutical Bulletin · 2002 · 63 citations · Full text

Medicine, Oncology, Pharmacology +11

Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1

Dominique Potin, Michèle Launay, Francoise Monatlik et al. · Journal of Medicinal Chemistry · 2006 · 51 citations · Full text

Medicine, Immunology, Pharmacology +17

Acridone-Based Inhibitors of Inosine 5‘-Monophosphate Dehydrogenase:  Discovery and SAR Leading to the Identification of <i>N</i>-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)

Scott H. Watterson, Ping Chen, Yufen Zhao et al. · Journal of Medicinal Chemistry · 2007 · 49 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)

Scott H. Watterson, Zili Xiao, Dharmpal S. Dodd et al. · Journal of Medicinal Chemistry · 2010 · 43 citations · Full text

Life Sciences, Immunology, Pharmacology +16